Quote | Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Last: | $6.9501 |
---|---|
Change Percent: | 2.68% |
Open: | $6.9 |
Close: | $6.9501 |
High: | $6.9501 |
Low: | $6.8 |
Volume: | 913 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Pasithea Therapeutics Corp. (NASDAQ:KTTA)
SOUTH SAN FRANCISCO, Calif. and MIAMI, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor for the ...
2024-04-16 18:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Subject | By | Source | When |
---|---|---|---|
*Pasithea Therapeutics Investor Camac Partners Reported Purchase of | Zorro | investorshub | 08/20/2022 4:01:55 PM |
MIAMI BEACH, Fla., Aug. 18, 2022 (GLOBE NEWSWIRE) | subslover | investorshub | 08/19/2022 12:23:32 PM |
great volume day yesterday on that news | $treet $inatra | investorshub | 08/12/2022 2:32:41 PM |
what does their balance sheet look like? | Hercules1 | investorshub | 08/12/2022 12:00:04 AM |
Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating | subslover | investorshub | 08/11/2022 12:11:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and MIAMI, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor for the ...
2024-04-16 18:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...